期刊文献+

左西孟旦治疗急性心力衰竭60例临床疗效观察 被引量:4

下载PDF
导出
摘要 目的:对左西孟旦治疗急性心力衰竭60例临床疗效的临床疗效进行观察和分析。方法:资料随机选取2012年6月~2013年6月我院收治的急性心力衰竭患者60例,将其平均分为两组,给予研究组患者左西孟旦进行治疗,对照组患者则采用多巴酚丁胺进行治疗;并对两组临床资料进行回顾性分析。结果:治疗前,两组LVEF、SV、LVEDD及LVSDD等比较无明显差异(P>0.05)。治疗后,研究组LVEF、SV,明显优于对照组,比较有差异具有统计学意义(P<0.05);两组LVEDD、LVSDD比较无明显差异(P>0.05)。结论:左西孟旦治疗急性心力衰竭的临床疗效较为显著,值得在临床中推广应用。
出处 《中国农村卫生》 2014年第2期40-41,共2页
  • 相关文献

参考文献3

二级参考文献23

  • 1张博晴,孙烈,杨季明,蒋振忠,周海波.重组人脑利钠肽与硝酸甘油治疗老年人急性左心衰竭中的疗效比较[J].临床荟萃,2007,22(5):352-353. 被引量:12
  • 2Dec GM. Acute decompensated heart failure : the shrinking role of inotropic therapy[ J]. J Am Coil Cardiol, 2005,46( 1 ) :65457.
  • 3Kivikko M, Lehtonen L, Colucci WS, et al. Sustained hemodynamic effects of intravenous levosimendan[J]. Circulation, 2003,107(1) :81-86.
  • 4Mebazaa A, Erhardt L. Levosimendan: a new dual-action drug in the treatment of acute heart failure[J]. Int J Clin Pract, 2003,57(5) :410M-16.
  • 5Grossini E, Caimmi PP, Molinari C. Hemodynamic effect of intracoronary ad- ministration of levosimendan in the anesthetized pig [ J ]. J Caidiovasc Plasma- col, 2005,46(3) :333-342.
  • 6Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosi- mendan compared with dobutamine in severe low-out-put heart failure (the LIDO study) : a randomized double-blind trial[J]. Lancet, 2002,360(9328) : 196-202.
  • 7Nieminen MS, Bohm M. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure[J]. Ital Heart J Suppl, 2005,6(4) :218- 254.
  • 8Ferenc F. Newer treatments for deeompensated heart failure: focus on levosi- mendan[ J]. Drug Des Devel, 2009,3:37-78.
  • 9Cleland JG, Ghosh J, Freemanth N, et al. Clinical trials update and cumulative meta-analyses fi'om the American College of Cardiology : WATCH, SCD-HePT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resyn- chronisation therapy in heart failure [ J ]. Eur J Heart Fail, 2004,6 (4) : 501- 508.
  • 10Cleland JG, Freemantle N, Coletta AP,et al. Clinical trims update from the A- merican Heart Association: REPAIR-AMI, ASTAMI, JELLS, MEGA, REVIVE I] , SURIVIVE and PROACTIVE[J] Eur J Heart Fail, 2006, 8 ( 1 ) : 105- 110.

共引文献24

同被引文献38

  • 1张健,杨跃进.急性心力衰竭的诊断和处理原则[J].中华心血管病杂志,2006,34(11):1053-1056. 被引量:31
  • 2杨跃进,尹栋,黄洁.心力衰竭的进展 (16)难治性心力衰竭的治疗原则和措施(续11)[J].中国循环杂志,2007,22(4):243-245. 被引量:7
  • 3Roger VL. Epidemiology of heart failure [ J ]. Circ Res, 2013,113 (6) : 646 - 659.
  • 4Jhund PS, Macintyre K, Simpson CR, et al. Long-term trends in first hos- pitalization for heart failure and subsequent survival between 1986 and2003 : a population study of 5,1 million people [ J ]. Circulation, 2009, 119(4) :515 -523.
  • 5Goldberg R J, Spencer FA, Farmer C, et al. Incidence and hospital death rates associated with heart failure :a community-wide perspective [ J ]. Am J Med,2005,118(7) :728 -734.
  • 6Bleumink GS, Knetsch AM, Suturkenboom MC, et al. Quantifying the heart failure epidemic : prevalence, incidence rate ,lifetime risk and prog- nosis of heart failure the rotterdam study [ J ]. Eur Heart J, 2004,25 (18) :1614 -1619.
  • 7Burger A J, Horton DP, LeJemtel T, et al. Effect of nesiritide ( B-typena- triuretic peptide) and dobutamine on ventricular arrhythmias in the treat- ment of patients with acutely decompensated congestive heart failure: the precedent study[ J]. Am Heart J ,2002,144 : 1102 - 1108.
  • 8Rognoni A, Lupi A, Lazzero M, et al. Levosimendan : from basic science to clinical trials [ J ]. Recent Pat Cardiovasc Drug Discov, 2011,6 : 9 - 15.
  • 9Kasikcioglu HA, Uyarel H,Tartan Z, et al. Do calcium sensitizers affect fight ventricular functions in patients with chronic heart failure? [ J ]. Int J Cardio1,2007, ( 118 ) :246 - 248.
  • 10Samimi FS, Garcia-Gonzlez MJ, Domfnguez-Rodrtguez A, et al. Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty[ J]. Int J Car- dio1,2008, ( 127 ) :284 - 287.

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部